 |
|
Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer
Youjin Lee, Byung-Ho Yoon, Seeyoun Lee, Youn Kyung Chung, Young-Kyun Lee
J Bone Metab. 2019;26(1):45-50. Published online 2019 Feb 28 DOI: https://doi.org/10.11005/jbm.2019.26.1.45
|
|
Citations to this article as recorded by
 Outcomes and Trends of Treatments in High‐Risk Differentiated Thyroid Cancer
Arash Abiri, Khodayar Goshtasbi, Sina J. Torabi, Edward C. Kuan, William B. Armstrong, Tjoson Tjoa, Yarah M. Haidar
Otolaryngology–Head and Neck Surgery.2023;[Epub] CrossRef Fracture risk and assessment in adults with cancer
Carrie Ye, William D. Leslie
Osteoporosis International.2023; 34(3): 449. CrossRef Analyses of the Association between Thyroid Cancer and Osteoporosis/Fracture Histories: A Cross-Sectional Study Using KoGES HEXA Data
Young-Ju Jin, Chang-Myeon Song, Bum-Jung Park, Hyo-Geun Choi
International Journal of Environmental Research and Public Health.2021; 18(9): 4732. CrossRef A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
Eun Kyung Lee, Yea Eun Kang, Young Joo Park, Bon Seok Koo, Ki-Wook Chung, Eu Jeong Ku, Ho-Ryun Won, Won Sang Yoo, Eonju Jeon, Se Hyun Paek, Yong Sang Lee, Dong Mee Lim, Yong Joon Suh, Ha Kyoung Park, Hyo-Jeong Kim, Bo Hyun Kim, Mijin Kim, Sun Wook Kim, Ka
Endocrinology and Metabolism.2021; 36(3): 574. CrossRef Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
Current Diabetes Reviews.2020; 16(9): 984. CrossRef
|